University of Cambridge > > Computational and Systems Biology > Understanding tumour heterogeneity in glioblastoma

Understanding tumour heterogeneity in glioblastoma

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Emily Boyd.

We have undertaken an integrated genomic analysis of the evolution of Glioblastoma (GB) in individual patients across multiple spatial scales. Our data reveal early clonal diversification generating a genetically complex and highly evolved disease environment at clinical presentation. We propose that these fundamental patient-specific tumor evolutionary dynamics underlie clinical phenotypic heterogeneity and may have implications for the emergence of resistant disease. Using a Fluorescence-Guided Multiple Sampling technique we obtained samples from the tumor mass, the sub-ependymal zone and the non-fluorescent tumor margin. These data allow us to study intra-tumour heterogeneity, which is likely to be the key to understanding treatment failure. I will describe our approach, and discuss a statistical problem that arises in the analysis of dependent samples.

This talk is part of the Computational and Systems Biology series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2023, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity